• Products
    • Pritumumab
    • CLNH5
    • MultiPharm
  • Investors
    • Corporate Governance
    • Contact Investor Relations
  • News
  • About
    • Corporate Management
    • Board of Directors
    • Science Advisory Board
  • Contact
Development and delivery of human antibodies for the treatment of cancer Development and delivery of human antibodies for the treatment of cancer Development and delivery of human antibodies for the treatment of cancer
  • Products
    • Pritumumab
    • CLNH5
    • MultiPharm
  • Investors
    • Corporate Governance
    • Contact Investor Relations
  • News
  • About
    • Corporate Management
    • Board of Directors
    • Science Advisory Board
  • Contact

Archives

Monthly Archive for: "April, 2020"
 Nascent Biotech: This Cancer Research Microcap Has A Drug in Testing with Indications for Use Against COVID-19
 0
By Nascent Biotech
In News
Posted April 8, 2020

Nascent Biotech: This Cancer Research Microcap Has A Drug in Testing with Indications for Use Against COVID-19

As the world of pharma and biotech companies works towards finding a solution for COVID-19, we see a number of different research-oriented companies emerging. Many of these companies specialize [...]

READ MORE
 Nascent Biotech’s Independent Consultants have begun Research on Pritumumab as a Potential Therapeutic Agent against (Coronavirus) Covid-19
 0
By Nascent Biotech
In News
Posted April 8, 2020

Nascent Biotech’s Independent Consultants have begun Research on Pritumumab as a Potential Therapeutic Agent against (Coronavirus) Covid-19

April 7, 2020 San Diego, CA USA. – Nascent Biotech, Inc. (OTCQB: NBIO), today announced that two independent consultants retained by the Company have begun preliminary research on a [...]

READ MORE
© NASCENT BIOTECH, INC. ALL RIGHTS RESERVED.